Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.WuXi PharmaTech, a biotechnology and medical device R&D outsourcing company, has appointed Jeff Leng to its board of directors. Mr Leng is replacing Sean Tong, formerly with General Atlantic, on the WuXi board.
Subscribe to our email newsletter
Mr Leng has been working for General Atlantic since 2007 and is based in China. Prior to joining General Atlantic, Mr Leng served as a managing director at Warburg Pincus. Mr Leng holds an MBA degree from the Wharton School at the University of Pennsylvania.
Ge Li, chairman and CEO of WuXi PharmaTech, said: “We thank Sean for his invaluable contributions and leadership to the board, and we are pleased to welcome Jeff to the WuXi board. Jeff brings with him invaluable experience as an investor and advisor to growth companies. We will employ his expertise as we position WuXi for the future to meet and anticipate the services that our customers will require as their businesses evolve.”